Orka Two vs Otofonix Encore

The Orka Two is a behind-the-ear prescription hearing aid priced at $1,899, earning an A grade with a SoundScore of 4.0/5 in our lab testing. It ranks #27 of 39 devices in the Prescription Hearing Aid category, placing it in the top 67% of its class. In our testing, the Orka Two demonstrates notable strengths in several areas. Speech in quiet environments scores a solid 3.7/5, measuring 0.32 points above the category average. Music streaming quality also performs well at 3.3/5, sitting 0.54 points above average—a plus for users who frequently stream audio from their phones. Own-voice comfort scores 3.2/5, which is 0.50 points above the category norm, and feedback handling is excellent at a perfect 5.0/5. The device's most significant limitation is speech understanding in noisy environments, where it scores 1.4/5—a low result that falls 0.71 points below the category average. This weakness may impact users who frequently encounter challenging listening situations like busy restaurants or social gatherings. The Orka Two includes Bluetooth streaming for both iPhone and Android devices, hands-free calling capability, and rechargeable batteries. While it delivers solid overall performance for its price tier, shoppers comparing options in this range should note that some competitors like the Rexton Reach R-Li T80 at Costco achieve higher overall scores. The Orka Two is best suited for users who prioritize quiet conversation clarity, streaming quality, and comfort, and who encounter noisy environments less frequently.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.